Priority Date: 25.01.07 (EP 20070447006)

Treatment of immune disease by mucosal delivery of antigens

  • Application ID: EP14169790
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorneys

operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
operating since 2000
Headquarter in Munich
active in Legal Services and IP Consulting
Employment test 201 - 500 employees
Company dna nlo
operating since 1888
Headquarter in The Hague and 3 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and De Clercq & Partners cvba are specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 172 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 25.01.2007 - Priority Date (EP 20070447006)
  • 10.09.2014 - Publication A2 (EP2774621)
  • 26.11.2014 - Publication A3 (EP2774621)